High Outlier
DEA Schedule CIII
Strength
100 mg/mL
Manufacturer
Hospira Inc.NDC
00409004010
Classification
Generic
Dosage Form
INJECTION, SOLUTION, CONCENTRATE
Route
INTRAMUSCULAR; INTRAVENOUS
Last Updated
4/22/2026
Active Ingredients
KETAMINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA074549On Market Since
10/10/2022
Pharmacological Classes
General Anesthesia
General Anesthetic
Generic Alternatives
No alternatives available
No alternatives found with the same active ingredient, strength, and dosage form.
Related Drugs
Same classification
PROPOFOL 200 MG/20 ML VIAL
Generic
00409601025•Hospira Inc.
$0.1750
per ML
PROPOFOL 200 MG/20 ML VIAL
Generic
25021060820•Sagent Pharmaceuticals
$0.1750
per ML
PROPOFOL 200 MG/20 ML VIAL
Generic
43598026525•Dr. Reddy's Laboratories Inc.
$0.1750
per ML
KETAMINE 500 MG/10 ML VIAL
Generic
00143950810•Hikma Pharmaceuticals USA Inc.
$0.5215
per ML
KETAMINE 500 MG/10 ML VIAL
Generic
00409205310•Hospira Inc.
$0.5215
per ML
KETAMINE 500 MG/10 ML VIAL
Generic
25021068310•Sagent Pharmaceuticals
$0.5215
per ML
KETAMINE 500 MG/10 ML VIAL
Generic
65219018810•Fresenius Kabi USA, LLC
$0.5215
per ML
KETAMINE 500 MG/10 ML VIAL
Generic
72572032010•Civica, Inc.
$0.5215
per ML
KETAMINE 500 MG/5 ML VIAL
Generic
00143950910•Hikma Pharmaceuticals USA Inc.
$1.5655
per ML
KETAMINE 500 MG/5 ML VIAL
Generic
00409205105•Hospira Inc.
$1.5655
per ML